Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of)
News
Takeda Pharmaceutical Company Limited (NYSE:TAK) Shares Acquired by Raymond James & Associates
Zolmax Raymond James Associates grew its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 5.3% in the 2nd quarter, according to the company in its most recent filing with...\n more…
Takeda Releases New Report to Support Health System Readiness for Rare Diseases in Canada
CNW Group - News Releases Takeda Releases New Report to Support Health System Readiness for Rare Diseases in Canada Takeda Releases New Report to Support Health System Readiness for Rare Diseases in Canada Canada NewsWire...\n more…
Takeda Receives European Commission Approval for ADZYNMA (Recombinant ADAMTS13) as the First and Only Recombinant ADAMTS13 Replacement Therapy for Congenital Thrombotic Thrombocytopenic Purpu
Business Wire Takeda (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) approved ADZYNMA (recombinant ADAMTS13) for the treatment of ADAMTS13 deficiency in children and adult patients with...\n more…
Takeda Pharmaceutical Company Limited (NYSE:TAK) Shares Bought by Russell Investments Group Ltd.
Zolmax Russell Investments Group Ltd. lifted its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 65.2% in the 1st quarter, according to its most recent 13F filing with...\n more…
Takeda Pharmaceutical Company Limited (TAK) Q1 2025 Earnings Call Transcript
SeekingAlpha Takeda Pharmaceutical Company Limited (TAK) Q1 2025 Earnings Call Transcript...\n more…
TAK Makes Bullish Cross Above Critical Moving Average
Market News Video In trading on Wednesday, shares of Takeda Pharmaceutical Co Ltd (TAK) crossed above their 200 day moving average of 13.88, changing hands as high as 13.91 per share. Takeda Pharmaceutical...\n more…